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In the pediatric age range, infection due to G. vaginalis is extremely uncommon, and invasive infections have been reported only during the neonatal period. 3 -11 In this report, we describe a 23-week premature infant with G. vaginalis bacteremia and present a review of the reported infections due to G. vaginalis in newborn infants.
CASE REPORT
A 560-g female infant was born prematurely at 23 weeks' gestation to a 17-year-old primigravida. The pregnancy was uncomplicated until the infant's mother presented in active labor with abdominal cramping and bloody vaginal discharge. The infant was delivered vaginally without complications and the Apgar scores were 5 and 8 at 1 and 5 minutes, respectively. Physical examination at birth revealed an extremely premature infant in respiratory distress, prompting intubation and assisted ventilation. A tracheal aspirate culture and blood culture were obtained and intravenous ampicillin and gentamicin were administered empirically for 72 hours.
Shortly after delivery, the infant's mother developed fever and abdominal pain and was diagnosed as having endometritis. A blood culture was obtained and this remained sterile. She received intravenous ampicillin-sulbactam, gentamicin, and metronidazole and her symptoms resolved within 4 days.
The infant remained clinically stable; however, on the fourth day of life the initial blood and tracheal aspirate cultures yielded pure growth of a Gram-negative bacillus identified as G. vaginalis. Repeat blood and tracheal aspirate cultures were obtained and cerebrospinal fluid (CSF) examination was performed. The CSF was benign; however, the white blood cell count was 24,200/mm 3 (66% neutrophils, 5% bands forms, and 29% lymphocytes). Kirby-Bauer antibiotic susceptibilities on the isolates were not performed because standards for interpretation are unavailable, and an attempt to perform macrobroth dilution susceptibilities was unsuccessful due to poor growth. On day of life 5, intravenous metronidazole (7.5 mg/kg) was administered every 48 hours for 10 doses. No additional problems associated with G. vaginalis were identified.
DISCUSSION

G. vaginalis was first described by Leopold in 1953 and was termed
Haemophilus vaginalis. 12 The name was later changed to Corynebacterium vaginale and to Gardnerella vaginalis in 1980 in honor of Dr. Herman Gardner.
13 G. vaginalis is a Gram-negative or variable bacillus that is characterized by its slow growth on ordinary media on which it is difficult to differentiate from other vaginal bacteria. On sheep blood agar G. vaginalis grows as pinpoint colonies anaerobically or in 5% carbon dioxide. The medium of choice for its isolation is Columbia agar with human blood, on which it causes hemolysis. 14 G. vaginalis is a normal component of the human vaginal flora and primarily is a pathogen of the female genitourinary tract. Bacterial vaginosis is the most common condition associated with this organism. 1, 2 In obstetrical patients, G. vaginalis is a recognized though uncommon cause of more serious infection. Reports have identified G. vaginalis as an etiologic agent in puerperal sepsis, 3,4,15 -18 endometritis, 15, 16, 19 and septic abortion. 4, 16 The pathogenesis of these infections is considered to represent opportunistic spread of the organism from the vagina to the uterus and urogenital tract as a result of mucosal injury during delivery.
Gardnerella vaginalis is a normal component of the human vaginal flora and commonly associated with bacterial vaginosis. Invasive infection in obstetrical patients due to G. vaginalis has also been reported. In the pediatric age range, infection due to G. vaginalis is extremely rare and limited to neonates. We describe a 23-week premature infant with G. vaginalis bacteremia and review the characteristics of neonatal G. vaginalis infection reported in the literature. Antibiotic susceptibility testing of G. vaginalis isolates has shown that penicillin, ampicillin, erthromycin, clindamycin, and vancomycin are effective in vitro. Perinatal/Neonatal Casebook
A review of the English-language literature revealed nine publications of neonatal infection with G. vaginalis 3 -11 (Table 1) . Our patient represents the most premature infant infected with G. vaginalis reported to date. Most of the infections in these infants were considered to arise due to exposure to maternal vaginal flora during childbirth. These infants received various antibiotics and the majority of them recovered without serious sequelae. Among the 15 infants described, only three infants died. These deaths were attributed to prematurity and severity of illness in the era before modern neonatal supportive care.
Treatment for G. vaginalis infection has focused primarily on recommendations for adults with genital tract infections. Metronidazole and clindamycin are recognized as effective treatment of bacterial vaginosis. 20 However, because extravaginal invasive infections from G. vaginalis occur, antibiotic susceptibility testing has been performed to screen for emergence of resistance and to identify other therapeutic options. 21 These studies have shown that other antibiotics are effective in vitro for treatment. Kharsany et al. 21 tested 93 isolates of G. vaginalis for their susceptibilities to 25 antibiotics. Minimal inhibitory concentrations (MICs) were determined by the agar dilution method. All strains were susceptible to penicillin (MIC 90 , 0.5 g/ml), ampicillin (MIC 90 , 0.5 g/ml), erythromycin (MIC 90 , 0.06 g/ml), clindamycin (MIC 90 , 0.03 g/ml) and vancomycin (MIC 90 , 0.5 g/ml). Most of the strains were susceptible to metronidazole (MIC 90 , 16 g/ml) although the hydroxy metabolite of metronidazole showed greater activity than the parent compound (MIC 90 , 4 g/ml). Marked resistance to amikacin (MIC 90 , 128 g/ml) and sulfamethoxazole (MIC 90 , >128 g/ml) was observed.
Our patient received ampicillin and gentamicin as empiric treatment for possible sepsis after the initial blood and tracheal aspirate cultures were obtained. It may be reasonable to assume that the repeat cultures were sterile due to the efficacy of ampicillin against G. vaginalis. Eight of the previously reported 15 infants received empiric penicillin or ampicillin which may have contributed to the resolution of their infection.
Our patient's presentation illustrates the unusual occurrence of G. vaginalis bacteremia in a premature neonate. The positive tracheal aspirate culture suggests that aspiration of contaminated maternal amniotic fluid may have provided the portal of entry for the infection. The delayed growth on culture media is characteristic for this fastidious organism and the mother's illness shortly following delivery suggests she may also have been infected with G. vaginalis. This patient serves as a reminder that vaginal delivery exposes infants to a myriad of potential bacterial pathogens. Gram-variable or Gram-negative bacilli seen on gram stain that are slow to grow in culture media should raise the suspicion for G. vaginalis infection. 
